reta buyout:Biogen Completes Acquisition of Reata Pharmaceuticals

Biogen Completes Acquisition of Reata Pharmaceuticals

Biogen Completes Acquisition of Reata Pharmaceuticals

2023年9月26日—BiogenInc.(Nasdaq:BIIB)–hascompletedtheacquisitionofReataPharmaceuticals,Inc.(Nasdaq:RETA),acompanyfocusedondevelopingtherapeutics.。其他文章還包含有:「Acquisition|REATAPHARMACEUTICALSINC」、「BiogenAnnounces$7.3BillionAcquisitionOfReata...」、「BiogentoAcquireReataPharmaceuticals」、「BiogentobuyReatafor$6.5billiontobulkupraredisease...」、「HowBiogenoutbidarival'large」、...

查看更多 離開網站

Provide From Google
Acquisition | REATA PHARMACEUTICALS INC
Acquisition | REATA PHARMACEUTICALS INC

https://www.solactive.com

Due to the acquisition of REATA PHARMACEUTICALS INC-A by BIOGEN INC, the following treatment will be applied to the following indices: REATA ...

Provide From Google
Biogen Announces $7.3 Billion Acquisition Of Reata ...
Biogen Announces $7.3 Billion Acquisition Of Reata ...

https://www.investors.com

Biogen (BIIB) announced Friday it has agreed to acquire Reata Pharmaceuticals (RETA) for about $7.3 billion, boosting biopharmaceutical company Biogen's drug ...

Provide From Google
Biogen to Acquire Reata Pharmaceuticals
Biogen to Acquire Reata Pharmaceuticals

https://investors.biogen.com

Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion.

Provide From Google
Biogen to buy Reata for $6.5 billion to bulk up rare disease ...
Biogen to buy Reata for $6.5 billion to bulk up rare disease ...

https://www.reuters.com

Biogen agreed to buy rare disease drugmaker Reata Pharmaceuticals for nearly $6.5 billion, the first large acquisition under new CEO ...

Provide From Google
How Biogen outbid a rival 'large
How Biogen outbid a rival 'large

https://www.fiercepharma.com

Biogen's $7.3 billion buyout of Skyclarys-maker Reata Pharmaceuticals surprised some industry watchers last month.

Provide From Google
Reata shareholders clear buyout deal with Biogen
Reata shareholders clear buyout deal with Biogen

https://seekingalpha.com

Reata Pharmaceuticals (RETA) said that its shareholders approved its previously disclosed acquisition by Biogen (BIIB) at a special meeting ...

Provide From Google
Reata Stock Surges. Biogen Is Buying It for $7.3 Billion in ...
Reata Stock Surges. Biogen Is Buying It for $7.3 Billion in ...

https://www.barrons.com

Biogen will acquire Reata for $172.50 a share in cash, expanding its portfolio of neuromuscular disease treatments.